抗氧化剂和氧化复原旌旗灯号 SCIE

期刊简介估计审稿时候： 普通,3-6周

Antioxidants & Redox Signaling (ARS) is the leading peer-reviewed journal dedicated to understanding the vital impact of oxygen and oxidation-reduction (redox) processes on human health and disease. The Journal explores key issues in genetic, pharmaceutical, and nutritional redox-based therapeutics. Cutting-edge research focuses on structural biology, stem cells, regenerative medicine, epigenetics, imaging, clinical outcomes, and preventive and therapeutic nutrition, among other areas.

ARS has expanded to create two unique foci within one journal: ARS Discoveries and ARS Therapeutics. ARS Discoveries (24 issues) publishes the highest-caliber breakthroughs in basic and applied research. ARS Therapeutics (12 issues) is the first publication of its kind that will help enhance the entire field of redox biology by showcasing the potential of redox sciences to change health outcomes.

ARS coverage includes:

-ROS/RNS as messengers

-Ga搜索引擎优化us signal transducers

-Hypoxia and tissue oxygenation

-microRNA

-Prokaryotic systems

-Lessons from plant biology

《抗氧化剂与氧化复原旌旗灯号》（ARS）是抢先的同业评审期刊，努力于领会氧气和氧化复原（氧化复原）进程对人类安康和疾病的主要影响。该期刊切磋遗传、药物和养分氧化复原疗法中的关头题目。前沿研讨偏重于布局生物学、干细胞、再生医学、表观遗传学、成像、临床功效和防备和医治养分等范畴。

ARS 已扩大为在一本期刊中建立两个怪异的核心：ARS Discoveries 和 ARS Therapeutics。ARS Discoveries（24 期）颁发根本和利用研讨范畴中最高程度的冲破性功效。 ARS Therapeutics（共 12 期）是同类出书物中的第一本，它将经由过程展现氧化复原迷信转变安康功效的潜力，赞助晋升全部氧化复原生物学范畴。

ARS 报道包含：

-ROS/RNS 作为信使

-气体旌旗灯号传感器

-缺氧和构造氧合

-microRNA

-原核系统

-动物生物学的经历经验

《Antioxidants & Redox Signaling》(抗氧化剂和氧化复原旌旗灯号)编辑部通信体例为MARY ANN LIEBERT INC, 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, USA, NY, 10801。若是您须要辅佐投稿或润稿办事，您可以或许征询咱们的客服教员。咱们专一于期刊征询办事十年，熟习颁发政策，可为您供给一对一投稿指点，防止您在投稿时频仍碰鼻，节流您的可贵时候，有用晋升颁发机率，确保SCI检索（检索不了全额退款）。咱们视诺言为生命，多方面确保文章宁静失密，在任何环境下都不会泄漏您的小我信息或稿件内容。